The chief executive of Swiss drugmaker Novartis (NOVN.VX: Quote, Profile, Research) ruled out the possibility of making a hostile bid for another drug maker in an interview with French daily Le Figaro.
The chief executive of Swiss drugmaker Novartis (NOVN.VX: Quote, Profile, Research) ruled out the possibility of making a hostile bid for another drug maker in an interview with French daily Le Figaro.
